Philippe Genne

Philippe Genne is a seasoned leader in cancer treatment research and development, currently serving as the PDG of Oncodesign Precision Medicine (OPM), a company established in Dijon in September 2022. Previously, Philippe Genne founded Oncodesign in 1995, also focused on discovering new anticancer therapies. Earlier career experience includes serving as the International Project Manager at Debiopharm, where responsibilities involved clinical development, and conducting research at Texinfine and GSK. Philippe Genne holds advanced degrees in pharmacology and immunology from Université de Bourgogne and Université Claude Bernard Lyon 1.